Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.
Global Market Segmentation:
The report segments the global market by product and service, sample type, end user, and region.
Based on product, the market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2017. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.
The global market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2017, however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.
Based on end users, the market is segmented into workplaces, criminal justice systems and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. In 2017, the workplace testing segment is expected to account for the largest share of the market. The growth of this end-user segment can be attributed to the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory.
Get Expert Analysis and Insights of Global Market | Request Sample Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
What Drives the Market?
1. Growing Drug & Alcohol Consumption
2. Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
3. Presence of Government Funding in Major Markets
4. Regulatory Approvals & Product Launches and Services
Geographical Growth Analysis:
The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.
Key Players and Strategies Adopted by Them:
Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering drug screening services.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162987773
People who are subject to alcohol at times do horrendous things anyway this doesn't make them on an extremely fundamental level awful people. All around, being reliant on alcohol can genuinely influence the body and the cerebrum and can cause changes in people's perspectives, habits of reasoning and lead. Luckily countless these movements can be finished or exchanged through ending drinking - alcohol rehab can help with this. Alcohol reliance is a sickness, not a character blemish.
ReplyDeletealcohol rehab florida